Novel GPCR Internalization Assays Enable Drug Discovery
11 Apr 2011
In this interview at SBS 2011, DiscoveRx discuss the new PathHunter® GPCR eXpress Internalization Assay. These chemiluminescent assays can be used to measure functionalisation and endocytosis of GPCRs. In addition, DiscoveRx announce the merger with KINOMEscan™, to provide a profiling service for measuring the interaction of compounds against kinsases to discover putative drug candidates.
About the company
DiscoveRx Corporation
DiscoveRx is a fast growing innovative company that develops, manufactures, and commercializes reagents and complete assay kits for the drug discovery and screening markets. Our products, which include both in vitro biochemical assays and cell-based assays, enable customers to improve research productivity and effectiveness, thus accelerating the discovery and development of new drugs.
